Join Eoin Tabb on the Irish Haematology Oncology Podcast as he delves into the common skin reactions caused by cancer treatments. This episode is a must-listen for healthcare professionals seeking to enhance patient care by understanding, preventing, and managing these often-overlooked side effects. From acneiform rash to hand-foot syndrome, hair loss, drug-induced pruritus, paronychia, and onycholysis, Eoin breaks down the incidence, diagnosis, pathology, and treatment options for each condition. Gain valuable insights and practical tips to improve your patients' quality of life during their cancer journey. Tune in and empower yourself to make a real difference in your patients' well-being.
In this episode of the Irish Haematology Oncology Podcast, host Eoin Tabb discusses common skin reactions caused by cancer treatments. He covers the following topics:
Acneiform Rash: Incidence, diagnosis, pathology, prevention, and treatment options, including topical steroids, oral antibiotics, and oral steroids.
Hand-Foot Syndrome (HFS): Incidence, diagnosis, pathology, prevention strategies (moisturizing, avoiding friction, protecting from heat), and treatment options (topical corticosteroids, pain relievers, keratolytics, cooling).
Chemotherapy-Induced Alopecia (CIA) and Endocrine Therapy-Induced Alopecia (EIA): Incidence, diagnosis, pathology, prevention (scalp cooling for CIA), and supportive care options (wigs, hairpieces, nutritional supplements).
Drug-Induced Pruritus: Incidence, diagnosis, severity rating scales, management options for mild, moderate, and severe cases (moisturizers, anti-itch creams, topical corticosteroids, oral antihistamines, gabapentin, pregabalin, oral corticosteroids).
Paronychia: Incidence, diagnosis, pathology, prevention (nail care, hygiene, moisturizing), and treatment options (topical antiseptics, corticosteroids, antibiotics, nail removal).
Taxane-Induced Onycholysis: Incidence, diagnosis, pathology, prevention (moisturizing, nail protection, cooling), and treatment options (nail care, antibiotics, nail removal).
Eoin emphasizes the importance of early intervention, open communication with patients, and tailoring treatment plans to individual needs. He also provides resources for further learning and encourages listeners to stay informed about the latest research and treatment options.
References:
Lacouture, M. E., Sibaud, V., Gerber, P. A., van den Hurk, C., Fernández-Peñas, P., Santini, D., ... & Jordan, K. (2021). Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines. Annals of Oncology, 32(2), 157-170.
Feedback Form: https://forms.gle/AEcFAHCnykCNkKDJ9
CPD IIOP Example Link: https://docs.google.com/document/d/1l6UeJ1hMIQaeVChTCq3_l5A_f9MPms_DaY4EZ-WNBv4/edit?usp=sharing
